Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Centrally Acting Drug Burden at Discharge on Long-Term Outcomes Among ICU Survivors.

Critical care medicine·2026
Same author

Real-world burden of hypertrophic cardiomyopathy on healthcare use and health-related quality of life in Italy, Spain, and the United States.

Journal of medical economics·2026
Same author

Clinical Applications of Theranostics.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same author

PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under Psilocybin.

Scientific data·2026
Same author

Successful bilateral electroconvulsive therapy for catatonia presenting with novel climbing behavior in an adolescent with <i>CACNA1A</i> pathogenic variant and autism spectrum disorder: a case report.

Frontiers in psychiatry·2026
Same author

A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy.

Cell·2026
Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026
Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026
Same journal

GID4-Recruiting PROTACs for BRD4 Degradation Overcome Resistance Driven by CRBN and VHL Deficiency.

Journal of medicinal chemistry·2026
Same journal

Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer.

Journal of medicinal chemistry·2026
Same journal

Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

Journal of medicinal chemistry·2026
Same journal

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.6K

Exploring Structural Parameters for Pretargeting Radioligand Optimization.

Jan-Philip Meyer1, Paul Kozlowski1, James Jackson1

  • 1Department of Radiology, Memorial Sloan Kettering Cancer Center , New York, New York 10065, United States.

Journal of Medicinal Chemistry
|September 1, 2017
PubMed
Summary
This summary is machine-generated.

This study optimized radioligands for pretargeting, improving tumor targeting and reducing radiation dose. Two lead candidates show rapid tumor uptake and high contrast for better cancer diagnosis and treatment.

More Related Videos

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
10:16

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

47.0K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.3K

Related Experiment Videos

Last Updated: Feb 23, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.6K
Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
10:16

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

47.0K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.3K

Area of Science:

  • Biomedical imaging
  • Radiopharmaceutical chemistry
  • Molecular imaging

Background:

  • Pretargeting strategies enhance payload specificity and reduce off-target radiation.
  • An 18F-based pretargeting approach using inverse electron demand Diels-Alder reactions was previously developed.
  • This method showed potential for visualizing pancreatic tumors in vivo.

Purpose of the Study:

  • To conduct a comprehensive structure-pharmacokinetic relationship study of novel radioligands.
  • To identify radiotracers with optimal pharmacokinetic and dosimetric properties for pretargeting.
  • To advance the design of next-generation pretargeting agents.

Main Methods:

  • Synthesized and evaluated a library of 25 novel radioligands.
  • Investigated structure-pharmacokinetic relationships in vivo.
  • Assessed tumor targeting, biodistribution, and dosimetric properties.

Main Results:

  • Identified key relationships between molecular structure and in vivo behavior.
  • Discovered two lead radioligand candidates with rapid tumor targeting.
  • Achieved high target-to-background activity concentration ratios at early time points.

Conclusions:

  • The structure-pharmacokinetic data are valuable for designing improved pretargeting agents.
  • Optimized radioligands can enhance diagnostic and therapeutic applications.
  • This work supports the clinical translation of advanced pretargeting strategies.